Advertisement

Topics

Vortex licenses Harvard's technology to use in liquid biopsy for cancer

15:40 EDT 18 Oct 2016 | Elsevier Business Intelligence

Vortex Biosciences Inc. exclusively licensed a series of four Harvard University patents related to a cell electroporation technology, which the company plans to use in its liquid biopsy instrument for cancer diagnosis.

Original Article: Vortex licenses Harvard's technology to use in liquid biopsy for cancer

NEXT ARTICLE

More From BioPortfolio on "Vortex licenses Harvard's technology to use in liquid biopsy for cancer"

Quick Search
Advertisement
 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...